-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on TransMedics Group, Raises Price Target to $166

Benzinga·12/08/2025 12:12:55
Listen to the news
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the price target from $148 to $166.